{"count": 119, "results": [{"_id": "36157468", "pmid": 36157468, "pmcid": "PMC9507474", "title": "Antihypertensive treatment improves glycemic control in patients with newly diagnosed type 2 diabetes mellitus: A prospective cohort study", "journal": "Front Endocrinol (Lausanne)", "authors": ["Li JC", "Cheng PC", "Huang CN", "Jian LF", "Wu YS", "Lin CL"], "date": "2022-09-09T00:00:00Z", "doi": "10.3389/fendo.2022.935561", "meta_date_publication": "2022", "meta_volume": "13", "meta_issue": "", "meta_pages": "935561", "score": 50274.586, "text_hl": "Antihypertensive treatment with @<m>CHEMICAL_Amlodipine</m> @CHEMICAL_MESH:D017311 @@@Amlodipine@@@ in addition to standard @DISEASE_Diabetes_Mellitus @DISEASE_MESH:D003920 @@@diabetes@@@ therapy improves glycemic control in @SPECIES_9606 @@@patients@@@ with @<m>DISEASE_Diabetes_Mellitus_Type_2</m> @DISEASE_MESH:D003924 @@@T2DM@@@. ", "citations": {"NLM": "Li JC, Cheng PC, Huang CN, Jian LF, Wu YS, Lin CL. Antihypertensive treatment improves glycemic control in patients with newly diagnosed type 2 diabetes mellitus: A prospective cohort study Front Endocrinol (Lausanne). 2022;13():935561. PMID: 36157468", "BibTeX": "@article{36157468, title={Antihypertensive treatment improves glycemic control in patients with newly diagnosed type 2 diabetes mellitus: A prospective cohort study}, author={Li JC and Cheng PC and Huang CN and Jian LF and Wu YS and Lin CL}, journal={Front Endocrinol (Lausanne)}, volume={13}, pages={935561}}"}}, {"_id": "36899369", "pmid": 36899369, "pmcid": "PMC10005920", "title": "Effect of olmesartan and amlodipine on serum angiotensin-(1-7) levels and kidney and vascular function in patients with type 2 diabetes and hypertension", "journal": "Diabetol Metab Syndr", "authors": ["Kim K", "Moon JH", "Ahn CH", "Lim S"], "date": "2023-03-11T00:00:00Z", "doi": "10.1186/s13098-023-00987-1", "meta_date_publication": "2023 Mar 11", "meta_volume": "15", "meta_issue": "1", "meta_pages": "43", "score": 50263.617, "text_hl": "Effect of @CHEMICAL_olmesartan @CHEMICAL_MESH:C437965 @@@olmesartan@@@ and @<m>CHEMICAL_Amlodipine</m> @CHEMICAL_MESH:D017311 @@@amlodipine@@@ on serum angiotensin-(1-7) levels and kidney and vascular function in @SPECIES_9606 @@@patients@@@ with @<m>DISEASE_Diabetes_Mellitus_Type_2</m> @DISEASE_MESH:D003924 @@@type 2 diabetes@@@ and @DISEASE_Hypertension @DISEASE_MESH:D006973 @@@hypertension@@@", "citations": {"NLM": "Kim K, Moon JH, Ahn CH, Lim S. Effect of olmesartan and amlodipine on serum angiotensin-(1-7) levels and kidney and vascular function in patients with type 2 diabetes and hypertension Diabetol Metab Syndr. 2023 Mar 11;15(1):43. PMID: 36899369", "BibTeX": "@article{36899369, title={Effect of olmesartan and amlodipine on serum angiotensin-(1-7) levels and kidney and vascular function in patients with type 2 diabetes and hypertension}, author={Kim K and Moon JH and Ahn CH and Lim S}, journal={Diabetol Metab Syndr}, volume={15}, number={1}, pages={43}}"}}, {"_id": "37866351", "pmid": 37866351, "pmcid": "PMC10652658", "title": "Effects of Aliskiren Monotherapy versus Amlodipine Monotherapy in Hypertensive Patients with Obesity or Type 2 Diabetes Mellitus", "journal": "Kidney Blood Press Res", "authors": ["Seki Y", "Morimoto S", "Kimura S", "Takano N", "Yamashita K", "Bokuda K", "Sasaki N", "Watanabe D", "Ichihara A"], "date": "2023-10-20T00:00:00Z", "doi": "10.1159/000533834", "meta_date_publication": "2023 Oct 20", "meta_volume": "", "meta_issue": "", "meta_pages": "", "score": 50252.96, "text_hl": "Effects of @CHEMICAL_aliskiren @CHEMICAL_MESH:C446481 @@@Aliskiren@@@ Monotherapy versus @<m>CHEMICAL_Amlodipine</m> @CHEMICAL_MESH:D017311 @@@Amlodipine@@@ Monotherapy in Hypertensive @SPECIES_9606 @@@Patients@@@ with @DISEASE_Obesity @DISEASE_MESH:D009765 @@@Obesity@@@ or @<m>DISEASE_Diabetes_Mellitus_Type_2</m> @DISEASE_MESH:D003924 @@@Type 2 Diabetes Mellitus@@@", "citations": {"NLM": "Seki Y, Morimoto S, Kimura S, Takano N, Yamashita K, Bokuda K, Sasaki N, Watanabe D, Ichihara A. Effects of Aliskiren Monotherapy versus Amlodipine Monotherapy in Hypertensive Patients with Obesity or Type 2 Diabetes Mellitus Kidney Blood Press Res. 2023 Oct 20;():. PMID: 37866351", "BibTeX": "@article{37866351, title={Effects of Aliskiren Monotherapy versus Amlodipine Monotherapy in Hypertensive Patients with Obesity or Type 2 Diabetes Mellitus}, author={Seki Y and Morimoto S and Kimura S and Takano N and Yamashita K and Bokuda K and Sasaki N and Watanabe D and Ichihara A}, journal={Kidney Blood Press Res}}"}}, {"_id": "31976814", "pmid": 31976814, "title": "Metabolic and Cardiovascular Effects of Switching Thiazides to Amlodipine in Hypertensive Patients With and Without Type 2 Diabetes (the Diuretics and Diabetes Control Study).", "journal": "Metab Syndr Relat Disord", "authors": ["Buscemi S", "Buscemi C", "Borzì AM", "Cosentino L", "Rosafio G", "Randazzo C", "Colomba D", "Di Raimondo D", "Pluchinotta FR", "Parrinello G"], "date": "2020-03-01T00:00:00Z", "doi": "10.1089/met.2019.0099", "meta_date_publication": "2020 Mar", "meta_volume": "18", "meta_issue": "2", "meta_pages": "110-118", "score": 50252.93, "text_hl": "Metabolic and Cardiovascular Effects of Switching @CHEMICAL_Thiazides @CHEMICAL_MESH:D049971 @@@Thiazides@@@ to @<m>CHEMICAL_Amlodipine</m> @CHEMICAL_MESH:D017311 @@@Amlodipine@@@ in @DISEASE_Hypertension @DISEASE_MESH:D006973 @@@Hypertensive@@@ @SPECIES_9606 @@@Patients@@@ With and Without @<m>DISEASE_Diabetes_Mellitus_Type_2</m> @DISEASE_MESH:D003924 @@@Type 2 Diabetes@@@ (the Diuretics and @DISEASE_Diabetes_Mellitus @DISEASE_MESH:D003920 @@@Diabetes@@@ Control Study).", "citations": {"NLM": "Buscemi S, Buscemi C, Borzì AM, Cosentino L, Rosafio G, Randazzo C, Colomba D, Di Raimondo D, Pluchinotta FR, Parrinello G. Metabolic and Cardiovascular Effects of Switching Thiazides to Amlodipine in Hypertensive Patients With and Without Type 2 Diabetes (the Diuretics and Diabetes Control Study). Metab Syndr Relat Disord. 2020 Mar;18(2):110-118. PMID: 31976814", "BibTeX": "@article{31976814, title={Metabolic and Cardiovascular Effects of Switching Thiazides to Amlodipine in Hypertensive Patients With and Without Type 2 Diabetes (the Diuretics and Diabetes Control Study).}, author={Buscemi S and Buscemi C and Borzì AM and Cosentino L and Rosafio G and Randazzo C and Colomba D and Di Raimondo D and Pluchinotta FR and Parrinello G}, journal={Metab Syndr Relat Disord}, volume={18}, number={2}, pages={110-118}}"}}, {"_id": "33431541", "pmid": 33431541, "title": "Treatment of calcium channel blocker-induced gingival overgrowth without modifying medication.", "journal": "BMJ Case Rep", "authors": ["Morikawa S", "Nasu M", "Miyashita Y", "Nakagawa T"], "date": "2021-01-11T00:00:00Z", "doi": "10.1136/bcr-2020-238872", "meta_date_publication": "2021 Jan 11", "meta_volume": "14", "meta_issue": "1", "meta_pages": "", "score": 50235.56, "text_hl": "The @SPECIES_9606 @@@patient@@@ had been on @CHEMICAL_Nifedipine @CHEMICAL_MESH:D009543 @@@nifedipine@@@ (40 mg/day) and @<m>CHEMICAL_Amlodipine</m> @CHEMICAL_MESH:D017311 @@@amlodipine@@@ (10 mg/day) medication for 5 years. ", "citations": {"NLM": "Morikawa S, Nasu M, Miyashita Y, Nakagawa T. Treatment of calcium channel blocker-induced gingival overgrowth without modifying medication. BMJ Case Rep. 2021 Jan 11;14(1):. PMID: 33431541", "BibTeX": "@article{33431541, title={Treatment of calcium channel blocker-induced gingival overgrowth without modifying medication.}, author={Morikawa S and Nasu M and Miyashita Y and Nakagawa T}, journal={BMJ Case Rep}, volume={14}, number={1}}"}}, {"_id": "26223257", "pmid": 26223257, "pmcid": "PMC4518654", "title": "A study about the relevance of adding acetylsalicylic acid in primary prevention in subjects with type 2 diabetes mellitus: effects on some new emerging biomarkers of cardiovascular risk", "journal": "Cardiovasc Diabetol", "authors": ["Derosa G", "Mugellini A", "Pesce RM", "D'Angelo A", "Maffioli P"], "date": "2015-07-30T00:00:00Z", "doi": "10.1186/s12933-015-0254-8", "meta_date_publication": "2015 Jul 30", "meta_volume": "14", "meta_issue": "", "meta_pages": "95", "score": 50076.754, "text_hl": "213 @SPECIES_9606 @@@patients@@@ with @<m>DISEASE_Diabetes_Mellitus_Type_2</m> @DISEASE_MESH:D003924 @@@type 2 diabetes mellitus@@@ and @DISEASE_Hypertension @DISEASE_MESH:D006973 @@@hypertension@@@ were randomized to @<m>CHEMICAL_Amlodipine</m> @CHEMICAL_MESH:D017311 @@@amlodipine@@@ 5 mg, or @<m>CHEMICAL_Amlodipine</m> @CHEMICAL_MESH:D017311 @@@amlodipine@@@ 5 mg + @CHEMICAL_Aspirin @CHEMICAL_MESH:D001241 @@@ASA@@@ 100 mg for 3 months (Phase A); then, if adequate blood pressure control was reached @SPECIES_9606 @@@patients@@@ terminated the study; otherwise, @<m>CHEMICAL_Amlodipine</m> @CHEMICAL_MESH:D017311 @@@amlodipine@@@ was up-titrated to 10 mg/day for further 3 months and compared to @<m>CHEMICAL_Amlodipine</m> @CHEMICAL_MESH:D017311 @@@amlodipine@@@ 10 mg + @CHEMICAL_Aspirin @CHEMICAL_MESH:D001241 @@@ASA@@@ 100 mg (Phase B). ", "citations": {"NLM": "Derosa G, Mugellini A, Pesce RM, D'Angelo A, Maffioli P. A study about the relevance of adding acetylsalicylic acid in primary prevention in subjects with type 2 diabetes mellitus: effects on some new emerging biomarkers of cardiovascular risk Cardiovasc Diabetol. 2015 Jul 30;14():95. PMID: 26223257", "BibTeX": "@article{26223257, title={A study about the relevance of adding acetylsalicylic acid in primary prevention in subjects with type 2 diabetes mellitus: effects on some new emerging biomarkers of cardiovascular risk}, author={Derosa G and Mugellini A and Pesce RM and D'Angelo A and Maffioli P}, journal={Cardiovasc Diabetol}, volume={14}, pages={95}}"}}, {"_id": "28490725", "pmid": 28490725, "pmcid": "PMC5432799", "title": "Effects of valsartan and amlodipine on oxidative stress in type 2 diabetic patients with hypertension: a randomized, multicenter study", "journal": "Korean J Intern Med", "authors": ["Kim HJ", "Han SJ", "Kim DJ", "Jang HC", "Lim S", "Choi SH", "Kim YH", "Shin DH", "Kim SH", "Kim TH", "Ahn YB", "Ko SH", "Kim NH", "Seo JA", "Kim HY", "Lee KW"], "date": "2017-05-01T00:00:00Z", "doi": "10.3904/kjim.2015.404", "meta_date_publication": "2017 May", "meta_volume": "32", "meta_issue": "3", "meta_pages": "497-504", "score": 50076.754, "text_hl": "There was a Japanese study showing that @<m>CHEMICAL_Amlodipine</m> @CHEMICAL_MESH:D017311 @@@amlodipine@@@ decreased oxidative stress in @SPECIES_9606 @@@patients@@@ with @<m>DISEASE_Diabetes_Mellitus_Type_2</m> @DISEASE_MESH:D003924 @@@type 2 diabetes@@@. ", "citations": {"NLM": "Kim HJ, Han SJ, Kim DJ, Jang HC, Lim S, Choi SH, Kim YH, Shin DH, Kim SH, Kim TH, Ahn YB, Ko SH, Kim NH, Seo JA, Kim HY, Lee KW. Effects of valsartan and amlodipine on oxidative stress in type 2 diabetic patients with hypertension: a randomized, multicenter study Korean J Intern Med. 2017 May;32(3):497-504. PMID: 28490725", "BibTeX": "@article{28490725, title={Effects of valsartan and amlodipine on oxidative stress in type 2 diabetic patients with hypertension: a randomized, multicenter study}, author={Kim HJ and Han SJ and Kim DJ and Jang HC and Lim S and Choi SH and Kim YH and Shin DH and Kim SH and Kim TH and Ahn YB and Ko SH and Kim NH and Seo JA and Kim HY and Lee KW}, journal={Korean J Intern Med}, volume={32}, number={3}, pages={497-504}}"}}, {"_id": "25014057", "pmid": 25014057, "pmcid": "PMC4126761", "title": "Functional Vascular Study in Hypertensive Subjects with Type 2 Diabetes Using Losartan or Amlodipine", "journal": "Arq Bras Cardiol", "authors": ["Pozzobon CR", "Gismondi RA", "Bedirian R", "Ladeira MC", "Neves MF", "Oigman W"], "date": "2014-07-01T00:00:00Z", "doi": "10.5935/abc.20140089", "meta_date_publication": "2014 Jul", "meta_volume": "103", "meta_issue": "1", "meta_pages": "51-9", "score": 50072.336, "text_hl": "Functional Vascular Study in @DISEASE_Hypertension @DISEASE_MESH:D006973 @@@Hypertensive@@@ Subjects with @<m>DISEASE_Diabetes_Mellitus_Type_2</m> @DISEASE_MESH:D003924 @@@Type 2 Diabetes@@@ Using @CHEMICAL_Losartan @CHEMICAL_MESH:D019808 @@@Losartan@@@ or @<m>CHEMICAL_Amlodipine</m> @CHEMICAL_MESH:D017311 @@@Amlodipine@@@", "citations": {"NLM": "Pozzobon CR, Gismondi RA, Bedirian R, Ladeira MC, Neves MF, Oigman W. Functional Vascular Study in Hypertensive Subjects with Type 2 Diabetes Using Losartan or Amlodipine Arq Bras Cardiol. 2014 Jul;103(1):51-9. PMID: 25014057", "BibTeX": "@article{25014057, title={Functional Vascular Study in Hypertensive Subjects with Type 2 Diabetes Using Losartan or Amlodipine}, author={Pozzobon CR and Gismondi RA and Bedirian R and Ladeira MC and Neves MF and Oigman W}, journal={Arq Bras Cardiol}, volume={103}, number={1}, pages={51-9}}"}}, {"_id": "26867060", "pmid": 26867060, "title": "Comparative study of the efficacy of olmesartan/amlodipine vs. perindopril/amlodipine in peripheral blood pressure after missed dose in type 2 diabetes.", "journal": "J Hypertens", "authors": ["Redon J", "Pichler G", "Missed Dose Study Group"], "date": "2016-02-01T00:00:00Z", "doi": "10.1097/HJH.0000000000000793", "meta_date_publication": "2016 Feb", "meta_volume": "34", "meta_issue": "2", "meta_pages": "359-67", "score": 50064.586, "text_hl": "Comparative study of the efficacy of @CHEMICAL_olmesartan @CHEMICAL_MESH:C437965 @@@olmesartan@@@/@<m>CHEMICAL_Amlodipine</m> @CHEMICAL_MESH:D017311 @@@amlodipine@@@ vs. @CHEMICAL_Perindopril @CHEMICAL_MESH:D020913 @@@perindopril@@@/@<m>CHEMICAL_Amlodipine</m> @CHEMICAL_MESH:D017311 @@@amlodipine@@@ in peripheral blood pressure after missed dose in @<m>DISEASE_Diabetes_Mellitus_Type_2</m> @DISEASE_MESH:D003924 @@@type 2 diabetes@@@.", "citations": {"NLM": "Redon J, Pichler G, Missed Dose Study Group. Comparative study of the efficacy of olmesartan/amlodipine vs. perindopril/amlodipine in peripheral blood pressure after missed dose in type 2 diabetes. J Hypertens. 2016 Feb;34(2):359-67. PMID: 26867060", "BibTeX": "@article{26867060, title={Comparative study of the efficacy of olmesartan/amlodipine vs. perindopril/amlodipine in peripheral blood pressure after missed dose in type 2 diabetes.}, author={Redon J and Pichler G and Missed Dose Study Group}, journal={J Hypertens}, volume={34}, number={2}, pages={359-67}}"}}, {"_id": "24860622", "pmid": 24860622, "pmcid": "PMC4032353", "title": "Effect of single tablet of fixed-dose amlodipine and atorvastatin on blood pressure/lipid control, oxidative stress, and medication adherence in type 2 diabetic patients", "journal": "Diabetol Metab Syndr", "authors": ["Tanaka M", "Nishimura R", "Nishimura T", "Kawai T", "Meguro S", "Irie J", "Saisho Y", "Itoh H"], "date": "2014-05-18T00:00:00Z", "doi": "10.1186/1758-5996-6-56", "meta_date_publication": "2014", "meta_volume": "6", "meta_issue": "", "meta_pages": "56", "score": 50064.574, "text_hl": "Effect of single tablet of fixed-dose @<m>CHEMICAL_Amlodipine</m> @CHEMICAL_MESH:D017311 @@@amlodipine@@@ and @CHEMICAL_Atorvastatin @CHEMICAL_MESH:D000069059 @@@atorvastatin@@@ on blood pressure/@CHEMICAL_Lipids @CHEMICAL_MESH:D008055 @@@lipid@@@ control, oxidative stress, and medication adherence in @<m>DISEASE_Diabetes_Mellitus_Type_2</m> @DISEASE_MESH:D003924 @@@type 2 diabetic@@@ patients", "citations": {"NLM": "Tanaka M, Nishimura R, Nishimura T, Kawai T, Meguro S, Irie J, Saisho Y, Itoh H. Effect of single tablet of fixed-dose amlodipine and atorvastatin on blood pressure/lipid control, oxidative stress, and medication adherence in type 2 diabetic patients Diabetol Metab Syndr. 2014;6():56. PMID: 24860622", "BibTeX": "@article{24860622, title={Effect of single tablet of fixed-dose amlodipine and atorvastatin on blood pressure/lipid control, oxidative stress, and medication adherence in type 2 diabetic patients}, author={Tanaka M and Nishimura R and Nishimura T and Kawai T and Meguro S and Irie J and Saisho Y and Itoh H}, journal={Diabetol Metab Syndr}, volume={6}, pages={56}}"}}]}